Riskpilot← Back to searchSign inGet full accessNelara Medical AB
ABActiveOrg 5593569121Hedåkersvägen 8Research and experimental development on natural sciences and engineering · NACE 7210Est. 20210 employees
Revenue 2025
SEK 197K
+5% vs 2024
EBITDA margin
63.8%
-17% vs 2024
Equity ratio
48.7%
Financial strength
Net profit 2025
SEK 98K
-17% vs 2024
| Revenue | SEK 197K | +5% |
| EBITDA | SEK 126K | -17% |
| Net profit | SEK 98K | -17% |
| Total assets | SEK 295K | -28% |
| Equity | SEK 144K | -27% |
| Employees | 0 | — |
Legal name
Nelara Medical AB
Org number
5593569121
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
27 december 2021
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget ska bedriva konsultverksamhet och undervisning inom medicin.
Address
Hedåkersvägen 8
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 449 | 241 | 188 | 197 |
| Staff expenses | — | — | — | — |
| EBITDA | 424 | 214 | 151 | 126 |
| Depreciation & amort. | — | — | — | — |
| EBIT | 424 | 214 | 151 | 126 |
| Net financials | −0 | 1 | −0 | −1 |
| Profit before tax | 324 | 165 | 150 | 125 |
| Tax | −67 | −34 | −32 | −27 |
| Net profit | 257 | 130 | 118 | 98 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 509 | 488 | 412 | 295 |
| Equity | 282 | 227 | 195 | 144 |
| Long-term debt | — | — | — | — |
| Short-term debt | 127 | 111 | 67 | 1 |
| Total debt | 127 | 111 | 67 | 1 |
EBITDA margin
63.8%
This company
15.8%
Market median
+304% vs market
20222025
Equity ratio
48.7%
This company
38.2%
Market median
+27% vs market
20222025
Return on equity
68.4%
This company
18.4%
Market median
+272% vs market
20222025
Net profit margin
49.9%
This company
8.1%
Market median
+516% vs market
20222025
Asset turnover
0.67×
This company
1.12×
Market median
-40% vs market
20222025
Debt / equity
1.05×
This company
0.62×
Market median
-69% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-12-27 – 2022-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
| Former (4) | ||
| Board of Directors | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Nelara Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Carl Arvid Ljung | Board of Directors | 0 companies |
| Lina Anna Elisabeth Nordström | Board of Directors | 0 companies |
| Lars Hugo Viking Rillner | Deputy Board Member | 0 companies |
| Anna Charlotte Ljung | Deputy Board Member | 0 companies |
| Henrik Daniel Karlsson | Deputy Board Member | 0 companies |
| Mikaela Jenni Berglund | Deputy Board Member | 0 companies |
| Rolf Carl Ragnar Ljung | Chairman | 0 companies |